Related Experiment Video
Updated: Jan 6, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Aortic valve-related aortopathy: assessing optimal timing of surgical intervention
Johannes Petersen1, Tatiana Sequeira-Gross1, Shiho Naito1
1Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany.
Insights
Optimal surgical timing for valve-related aortopathy is unclear. New biomarkers and flow pattern analysis may improve treatment decisions beyond traditional diameter measurements.
Area of Science:
- Cardiovascular Medicine
- Aortic Diseases
- Valvular Heart Disease
Background:
- Proximal aortic dilatation, termed valve-related aortopathy, frequently accompanies aortic valve diseases like bicuspid aortic valve and aortic stenosis.
- Current criteria for surgical intervention based solely on aortic diameter are insufficient.
- There is a need for advanced diagnostic tools to determine optimal surgical timing.
Purpose of the Study:
- To review recent literature on valve-related aortopathies and optimal surgical intervention timing.
- To highlight valve morphotype- and lesion-dependent aortopathies (bicuspid aortic valve vs. tricuspid aortic valve; stenosis vs. regurgitation).
- To discuss novel diagnostic markers for improved clinical decision-making.
Main Methods:
- Systematic literature search of PubMed and Embase databases up to July 2019.
- Review of current treatment options for valve-related aortopathies.
- Analysis of emerging serological and rheological markers.
Main Results:
- Valve morphotype (bicuspid vs. tricuspid) and lesion type (stenosis vs. regurgitation) influence aortopathy characteristics.
- Traditional diameter-based criteria have limitations in guiding surgical intervention.
- Serological biomarkers and rheological markers of flow eccentricity show potential.
Conclusions:
- A combination of serological biomarkers and quantitative rheological markers for transvalvular flow eccentricity may aid decision-making.
- Future risk scores integrating aortic diameter, biomarkers, flow patterns, connective tissue status, and valve morphology could personalize treatment strategies for valve-related aortopathy.
Abstract:
Introduction: Dilatation of the proximal aorta is often associated with an aortic valve disease (e.g. bicuspid aortic valve, aortic stenosis), so-called 'valve-related aortopathy.' The definition of optimal timing for surgical intervention in valve-related aortopathy remains incompletely clarified. The limited value of traditional diameter-based intervention criteria has been recognized and more sophisticated diagnostic tools are necessary.Areas covered: This article aims to give an overview on the most recent literature addressing the different forms of valve-related aortopathies and the optimal timing of surgical intervention. It highlights the valve morphotype-dependent (BAV vs TAV) and the valve lesion-dependent aortopathies (stenosis vs regurgitation) and outlines the current treatment options of those pathologies. Further, this review discusses novel serological and rheological markers, potentially helping in the decision-making process in valve-related aortopathy. Systematic literature searches were performed using PubMed and Embase up to July 2019.Expert opinion: The combination of serological biomarkers and quantitative rheological markers for transvalvular flow eccentricity might be an additional useful tool. A possible solution for the future could be a risk score which considers body-surface-adjusted aortic diameters, activity of certain circulating biomarkers, transvalvular flow patterns, possible connective tissue disorders, and the valve morphology to define an individualized treatment strategy.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care
Aortic Regurgitation I: Introduction
Aneurysm IV: Nursing Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation IV: Nursing Management

